Skip to search.
 FTSE 100 Up 0.41%

AbbVie Inc. (ABBV)

-NYSE
70.01 Down 0.15(0.21%) 31 Jul 21:03
|After Hours: : 70.01 0.00 (0.00%) 31 Jul 22:44
Add to Portfolio
Prev Close:70.16
Open:70.38
Bid:69.59 x 300
Ask:70.01 x 100
1y Target Est:75.87
Beta:1.56
Earnings Date:29 Oct - 2 Nov (Est.)
Day's Range:69.73 - 70.38
52wk Range:51.37 - 71.60
Volume:6,181,288
Avg Vol (3m):9,577,700
Market Cap:111.53b
P/E (ttm):54.44
EPS (ttm):1.29
Div & Yield:2.04 (3.00%)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ABBVDown 0.21%111.53b
MRKUp 0.75%166.57b
NVSUp 0.55%250.57b
PFEUp 0.92%222.05b

Key Statistics

Forward P/E (1 yr):13.92
P/S (ttm):5.33
Ex-Dividend Date:13-Jul-15

Analysts

Annual EPS Est (Dec-15) :4.26
Quarterly EPS Est (Sep-15) :1.07
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):0.99

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products include HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-o... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback